vs

Side-by-side financial comparison of NB Bancorp, Inc. (NBBK) and STEM, INC. (STEM). Click either name above to swap in a different company.

NB Bancorp, Inc. is the larger business by last-quarter revenue ($63.4M vs $47.1M, roughly 1.3× STEM, INC.). NB Bancorp, Inc. runs the higher net margin — 12.2% vs -33.9%, a 46.1% gap on every dollar of revenue. On growth, NB Bancorp, Inc. posted the faster year-over-year revenue change (33.9% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 22.6%).

NB Bancorp, Inc. is a U.S.-based bank holding company operating through its fully owned banking subsidiary. It provides a full range of retail and commercial banking services including various deposit products, consumer loans, residential mortgages, and small business financing solutions, primarily catering to individual and small-to-mid-sized enterprise customers across the New York metropolitan area.

StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.

NBBK vs STEM — Head-to-Head

Bigger by revenue
NBBK
NBBK
1.3× larger
NBBK
$63.4M
$47.1M
STEM
Growing faster (revenue YoY)
NBBK
NBBK
+49.4% gap
NBBK
33.9%
-15.6%
STEM
Higher net margin
NBBK
NBBK
46.1% more per $
NBBK
12.2%
-33.9%
STEM
Faster 2-yr revenue CAGR
STEM
STEM
Annualised
STEM
36.1%
22.6%
NBBK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NBBK
NBBK
STEM
STEM
Revenue
$63.4M
$47.1M
Net Profit
$7.7M
$-16.0M
Gross Margin
48.9%
Operating Margin
23.5%
-17.7%
Net Margin
12.2%
-33.9%
Revenue YoY
33.9%
-15.6%
Net Profit YoY
-50.6%
68.8%
EPS (diluted)
$0.19
$-4.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NBBK
NBBK
STEM
STEM
Q4 25
$63.4M
$47.1M
Q3 25
$51.7M
$38.2M
Q2 25
$51.2M
$38.4M
Q1 25
$47.4M
$32.5M
Q4 24
$47.3M
$55.8M
Q3 24
$42.6M
$29.3M
Q2 24
$41.7M
$34.0M
Q1 24
$42.1M
$25.5M
Net Profit
NBBK
NBBK
STEM
STEM
Q4 25
$7.7M
$-16.0M
Q3 25
$15.4M
$-23.8M
Q2 25
$14.6M
$202.5M
Q1 25
$12.7M
$-25.0M
Q4 24
$15.6M
$-51.1M
Q3 24
$8.4M
$-148.3M
Q2 24
$9.5M
$-582.3M
Q1 24
$8.7M
$-72.3M
Gross Margin
NBBK
NBBK
STEM
STEM
Q4 25
48.9%
Q3 25
35.5%
Q2 25
33.4%
Q1 25
32.4%
Q4 24
-4.4%
Q3 24
21.2%
Q2 24
27.6%
Q1 24
-95.0%
Operating Margin
NBBK
NBBK
STEM
STEM
Q4 25
23.5%
-17.7%
Q3 25
38.6%
-33.6%
Q2 25
36.6%
-34.8%
Q1 25
37.1%
-65.0%
Q4 24
40.7%
-84.4%
Q3 24
36.1%
-493.2%
Q2 24
28.3%
-1705.5%
Q1 24
28.8%
-267.0%
Net Margin
NBBK
NBBK
STEM
STEM
Q4 25
12.2%
-33.9%
Q3 25
29.7%
-62.2%
Q2 25
28.5%
527.8%
Q1 25
26.7%
-76.9%
Q4 24
33.0%
-91.6%
Q3 24
19.7%
-506.3%
Q2 24
22.7%
-1712.6%
Q1 24
20.7%
-283.9%
EPS (diluted)
NBBK
NBBK
STEM
STEM
Q4 25
$0.19
$-4.40
Q3 25
$0.43
$-2.84
Q2 25
$0.39
$-1.79
Q1 25
$0.33
$-0.15
Q4 24
$0.40
$-15.29
Q3 24
$0.21
$-18.24
Q2 24
$0.24
$-71.81
Q1 24
$0.22
$-0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NBBK
NBBK
STEM
STEM
Cash + ST InvestmentsLiquidity on hand
$48.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$858.9M
$-249.4M
Total Assets
$7.0B
$308.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NBBK
NBBK
STEM
STEM
Q4 25
$48.9M
Q3 25
$43.1M
Q2 25
$40.8M
Q1 25
$58.6M
Q4 24
$56.3M
Q3 24
$75.4M
Q2 24
$89.6M
Q1 24
$112.8M
Stockholders' Equity
NBBK
NBBK
STEM
STEM
Q4 25
$858.9M
$-249.4M
Q3 25
$737.0M
$-235.7M
Q2 25
$737.1M
$-214.1M
Q1 25
$739.6M
$-417.5M
Q4 24
$765.2M
$-398.4M
Q3 24
$747.4M
$-344.1M
Q2 24
$734.3M
$-203.2M
Q1 24
$733.8M
$371.6M
Total Assets
NBBK
NBBK
STEM
STEM
Q4 25
$7.0B
$308.9M
Q3 25
$5.4B
$362.6M
Q2 25
$5.2B
$379.2M
Q1 25
$5.2B
$405.1M
Q4 24
$5.2B
$437.4M
Q3 24
$5.0B
$537.8M
Q2 24
$4.8B
$691.5M
Q1 24
$4.7B
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NBBK
NBBK
STEM
STEM
Operating Cash FlowLast quarter
$60.8M
$8.2M
Free Cash FlowOCF − Capex
$57.4M
FCF MarginFCF / Revenue
90.6%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
7.89×
TTM Free Cash FlowTrailing 4 quarters
$117.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NBBK
NBBK
STEM
STEM
Q4 25
$60.8M
$8.2M
Q3 25
$24.2M
$11.4M
Q2 25
$27.0M
$-21.3M
Q1 25
$9.9M
$8.5M
Q4 24
$43.2M
$-14.7M
Q3 24
$8.6M
$-9.4M
Q2 24
$24.7M
$-11.9M
Q1 24
$-11.4M
$-621.0K
Free Cash Flow
NBBK
NBBK
STEM
STEM
Q4 25
$57.4M
Q3 25
$23.9M
Q2 25
$26.1M
Q1 25
$9.8M
Q4 24
$41.3M
Q3 24
$8.4M
Q2 24
$23.8M
Q1 24
$-11.7M
FCF Margin
NBBK
NBBK
STEM
STEM
Q4 25
90.6%
Q3 25
46.3%
Q2 25
51.0%
Q1 25
20.8%
Q4 24
87.2%
Q3 24
19.7%
Q2 24
57.1%
Q1 24
-27.7%
Capex Intensity
NBBK
NBBK
STEM
STEM
Q4 25
5.4%
Q3 25
0.6%
Q2 25
1.9%
Q1 25
0.2%
Q4 24
4.1%
Q3 24
0.5%
Q2 24
2.1%
Q1 24
0.6%
Cash Conversion
NBBK
NBBK
STEM
STEM
Q4 25
7.89×
Q3 25
1.58×
Q2 25
1.85×
-0.11×
Q1 25
0.79×
Q4 24
2.77×
Q3 24
1.03×
Q2 24
2.61×
Q1 24
-1.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons